"Grey's Anatomy" star Eric Dane has died at 53 following a battle with ALS. ALS, short for amyotrophic lateral sclerosis and also known as Lou Gehrig's disease, is a nervous system disease that ...
A genetics‑guided small molecule called compound 6 gently turns down an overactive immune pathway (CARD9), offering a more precise, durable, and potentially safer treatment strategy for Crohn’s ...
Scientists have long observed that cancer patients have a lower risk of Alzheimer’s disease. New research reveals a possible reason why. These brain scans of a 74-year-old patient with Alzheimer's ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. New gene therapies such as AMT‑130 are beginning to slow Huntington’s disease progression, ...
Barbara Jacquelyn Sahakian receives funding from the Wellcome Trust. Her research work is conducted within the NIHR Cambridge Biomedical Research Centre (BRC) Mental Health and Neurodegeneration ...
Scientists may have pinpointed a way to reverse Alzheimer’s disease in an animal study. The study, led by University Hospitals Cleveland Medical Center, found that restoring a central cellular energy ...
EDITOR’S NOTE: The podcast Chasing Life With Dr. Sanjay Gupta explores the medical science behind some of life’s mysteries big and small. You can listen to episodes here. The “Shaking Palsy.” Those ...
Those with the sleep condition were more likely to develop Parkinson’s disease. But one treatment was found to help. By Caroline Hopkins Legaspi In a study published Monday in JAMA Neurology, ...
What Is Crohn’s Constipation? You likely have constipation if it's hard for you to poop and you're having fewer bowel movements than you normally do. The same is true whether or not you have Crohn’s ...
Health officials in the mid-Atlantic region have recently reported a rise in hand, foot and mouth disease, or HFMD. What is hand, foot and mouth disease, and what causes it? How is it spread? What are ...
People affected by Huntington’s disease could at last benefit from the first treatment to slow the fatal neurodegenerative condition. Scientists from University College London (UCL) found patients ...